Publications by authors named "Ken Simmons"

Claim this Profile
A
Anti-C1s humanized monoclonal antibody SAR445088: A classical pathway complement inhibitor specific for the active form of C1s.
Ken T Simmons, Joanne Chan, Sami Hussain, Eileen L Rose, Kate Markham

Clin Immunol· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Preclinical Safety Study of Human Embryonic Stem Cell-Derived Retinal Pigment Epithelial Cells for Macular Degeneration.
John L Mazzilli, Joshua D Snook, Ken Simmons, Aleksey Y Domozhirov, Charles A Garcia

J Ocul Pharmacol Ther· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Complement Receptor 1 (CR1/CD35)-expressing retinal pigment epithelial cells as a potential therapy for age-related macular degeneration.
Ken T Simmons, John L Mazzilli, Stacey L Mueller-Ortiz, Aleksey Y Domozhirov, Charles A Garcia

Mol Immunol· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Protective role of commensal bacteria in Sjögren Syndrome.
Mahira Zaheer, Changjun Wang, Fang Bian, Zhiyuan Yu, Humberto Hernandez, Ken T Simmons

J Autoimmun· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inflammatory Response to Lipopolysaccharide on the Ocular Surface in a Murine Dry Eye Model.
Ken T Simmons, Yangyan Xiao, Stephen C Pflugfelder, Cintia S de Paiva

Invest Ophthalmol Vis Sci· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Histamine release associated with intravenous delivery of a fluorocarbon-based sevoflurane emulsion in canines.
Rebecca A Johnson, Ken T Simmons, Jonathan P Fast, Carrie A Schroeder, Robert A Pearce

J Pharm Sci· July 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis